Coronavirus Puts DOJ on Heightened Alert for Potential Fraud
![Medical Healthcare Science](/sites/default/files/styles/fullscreen_4x3_767x575_1x/public/2024-08/Medical%20Healthcare%20Science.jpg?itok=fS5BQMlq)
In this time of supreme uncertainty, companies have many urgent concerns.
Recent actions by the Department of Justice give businesses another thing to focus on: investigations and enforcement relating to fraud, waste, and abuse sure to trail in the wake of Covid-19 relief. Even if your company does not receive funds specifically tied to the federal government's response to the Covid-19 outbreak, you should bear in mind the risks of potential exposure to fraud allegations. Click here to read the full article as published in Bloomberg Law. Reproduced with permission. Published March 24, 2020. Copyright 2020 The Bureau of National Affairs, Inc. 800-372- 1033. For further use, please visit http://www.bna.com/copyright-permission-request/.
Print and share
Authors
Explore more in
White Collar Briefly
Drawing from breaking news, ever changing government priorities, and significant judicial decisions, this blog from Perkins Coie’s White Collar and Investigations group highlights key considerations and offers practical insights aimed to guide corporate stakeholders and counselors through an evolving regulatory environment. Subscribe 🡢